Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Seres Names Kurt Graves To Board

This article was originally published in Scrip

Executive Summary

Seres Therapeutics, a microbiome therapeutics platform company, has appointed Kurt Graves to its board of directors. Graves, the chair, president and CEO of Intarcia Therapeutics, brings to Seres extensive experience from his 25-year career at top-tier pharmaceutical and biotech companies. He has held the position of chair, president and CEO of Intarcia since April 2012, having previously served as the company's executive chair since 2010 and acting CEO since October 2011. Before joining Intarcia, Graves was executive vice president, chief commercial officer and head of corporate and strategic development at Vertex Pharmaceuticals. Graves is already chair of the board of Radius Health, and a director on the boards of both Achillion Pharmaceuticals and Pulmatrix Pharmaceuticals.

You may also be interested in...



Building The Talent Pipeline Starts With Access For All

Diversity in all forms is critical to innovation in health care, says AstraZeneca’s chief medical officer, Ann Taylor. In an exclusive interview, she talks about the company’s work in mentoring and education, and why tackling issues around diversity and inclusion must be driven by the C-suite alongside community initiatives. 

Snapshot: October Highlights

A selection of articles you might have missed from October 2020, including exclusive interviews with industry leaders and a deeper dive into the Femtech market.

Execs On The Move, Oct 2020

An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.

Related Companies

UsernamePublicRestriction

Register

OM006145

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel